R.PR
REGISTERED-PRINCIPAL REGISTER
11/09/2021
Back to search
Official data from USPTO
RETROLEAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
11/09/2021
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
10/26/2020
Registration date
11/09/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2021
Last transaction
11/09/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
16
Owner location
Shanghai, CN
Examiner
DETMER, CAROLYN ROSE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "RETROLEAD" in stylized letters.
Holders and representatives
Holders
Ruilidi (Shanghai) Biopharma Co., Ltd.
Representatives
Michael J. Turgeon VEDDER PRICE P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Injectable pharmaceuticals preparations for the prevention and treatment of viral and infectious diseasesfor the treatment of cancer; Injectable pharmaceuticals preparations for the prevention and treatment of bacteria-based diseases; Injectable pharmaceuticals preparations for the prevention and treatment of HIV/AIDS and hepatitis; Injectable pharmaceuticals preparations for the prevention and treatment of anaphylactic reactions; Medicinal preparations for the mouth to be applied in the form of capsules; Medicinal preparations for the mouth to be applied in the form of tablets; Biological preparations for the prevention and treatment of viral and infectious diseasesfor the treatment of cancer; Biological preparations for the prevention and treatment of HIV/AIDShepatitis and liver diseases; Biological preparations for the prevention and treatment of respiratory system diseases; Pharmaceutical preparations for the prevention and treatment of HIV/AIDS; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory syncytial virus; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseasesdiabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Medicines for antiviral purposes; Medicinal preparations for infective disorders; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the prevention and treatment of viral and infectious diseases; Dietetic foods adapted for medical use; Dietetic beverages adapted for medical use
Publications
History of USPTO decisions and trademark events.
17 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/24/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2021
GNRT
NON-FINAL ACTION E-MAILED
04/03/2021
CNRT
NON-FINAL ACTION WRITTEN
04/03/2021
DOCK
ASSIGNED TO EXAMINER
03/26/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/12/2021
ALIE
ASSIGNED TO LIE
03/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/04/2020
NWAP
NEW APPLICATION ENTERED
10/29/2020
Continuous trademark protection
Get notified about every new filing that threatens RETROLEAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.